HRP20030392A2 - Crystalline venlafaxine base and novel polymorphsof venlafaxine hydrochloride, processes for preparing thereof - Google Patents

Crystalline venlafaxine base and novel polymorphsof venlafaxine hydrochloride, processes for preparing thereof Download PDF

Info

Publication number
HRP20030392A2
HRP20030392A2 HR20030392A HRP20030392A HRP20030392A2 HR P20030392 A2 HRP20030392 A2 HR P20030392A2 HR 20030392 A HR20030392 A HR 20030392A HR P20030392 A HRP20030392 A HR P20030392A HR P20030392 A2 HRP20030392 A2 HR P20030392A2
Authority
HR
Croatia
Prior art keywords
venlafaxine hydrochloride
venlafaxine
solvent
crystalline
solvate
Prior art date
Application number
HR20030392A
Other languages
English (en)
Croatian (hr)
Inventor
Aronhime Judith
Nisnevish Gennady
Dolitzky Ben-Zion
Wizel Shlomit
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20030392(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of HRP20030392A2 publication Critical patent/HRP20030392A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20030392A 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphsof venlafaxine hydrochloride, processes for preparing thereof HRP20030392A2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24157700P 2000-10-19 2000-10-19
US25886100P 2000-12-29 2000-12-29
US27872101P 2001-03-26 2001-03-26
US29246901P 2001-05-21 2001-05-21
PCT/US2001/051017 WO2002045658A2 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (1)

Publication Number Publication Date
HRP20030392A2 true HRP20030392A2 (en) 2005-04-30

Family

ID=27500045

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030392A HRP20030392A2 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphsof venlafaxine hydrochloride, processes for preparing thereof

Country Status (20)

Country Link
US (1) US20020143211A1 (cs)
EP (1) EP1334082A4 (cs)
JP (2) JP2004530638A (cs)
KR (1) KR20030059206A (cs)
CN (1) CN1620420A (cs)
AU (1) AU2002241764A1 (cs)
CA (1) CA2426158A1 (cs)
CZ (1) CZ20031298A3 (cs)
DE (1) DE01988460T1 (cs)
ES (1) ES2206082T1 (cs)
HR (1) HRP20030392A2 (cs)
HU (1) HUP0303496A3 (cs)
IL (2) IL155400A0 (cs)
IS (1) IS6789A (cs)
MX (1) MXPA03003459A (cs)
NO (1) NO20031743L (cs)
PL (1) PL365895A1 (cs)
SK (1) SK5762003A3 (cs)
WO (1) WO2002045658A2 (cs)
YU (1) YU30203A (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP1330427A1 (en) 2000-10-31 2003-07-30 Ciba SC Holding AG Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
EP1451145A1 (en) 2001-12-05 2004-09-01 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2002247945A1 (en) * 2001-12-13 2003-06-23 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AR039164A1 (es) 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
AR039165A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Venlafaxina base
US6717015B2 (en) 2002-03-28 2004-04-06 Synthon Bv Venlafaxine besylate
DE10359154A1 (de) 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
EP1806335A4 (en) * 2004-10-20 2008-12-03 Mitsubishi Tanabe Pharma Corp METHOD FOR PRODUCING A PHENYLETHANOLAMINE COMPOUND AND INTERMEDIATE PRODUCTS THEREFOR
US20070129562A1 (en) * 2005-10-19 2007-06-07 Kansal Vinod K Process for the preparation of highly pure 1-[2- dimethylamino-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
WO2007049302A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of pure venlafaxine
US20100204470A1 (en) 2006-06-27 2010-08-12 Sandoz Ag method for salt preparation
AR062064A1 (es) * 2006-07-14 2008-10-15 Medichem Sa Prcesos mejorados para preparar una base de venlafaxina y sus sales
JP2014500234A (ja) * 2010-10-01 2014-01-09 シャンドン リュイェ ファーマシューティカル カンパニー リミテッド ４−［２−ジメチルアミノ−１−（１−ヒドロキシシクロヘキシル）エチル］フェニル４−メチルベンゾエートヒドロクロリドの多形体、それらを作製する方法及びそれらの使用
CN105916502A (zh) 2013-11-15 2016-08-31 阿克比治疗有限公司 {[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基}乙酸的固体形式，其组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
AR255595A1 (cs) 1994-07-13 2002-05-24 Gador Sa
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP1330427A1 (en) * 2000-10-31 2003-07-30 Ciba SC Holding AG Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en) * 2000-12-07 2002-06-13 Dr. Reddy's Laboratories Ltd. Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
EP1334082A2 (en) 2003-08-13
NO20031743L (no) 2003-06-18
KR20030059206A (ko) 2003-07-07
WO2002045658A2 (en) 2002-06-13
DE01988460T1 (de) 2004-04-22
EP1334082A4 (en) 2006-02-01
PL365895A1 (en) 2005-01-10
JP2004530638A (ja) 2004-10-07
AU2002241764A1 (en) 2002-06-18
HUP0303496A3 (en) 2005-08-29
US20020143211A1 (en) 2002-10-03
JP2008239629A (ja) 2008-10-09
HUP0303496A2 (hu) 2004-01-28
CZ20031298A3 (cs) 2003-10-15
IL196287A0 (en) 2011-08-01
WO2002045658A3 (en) 2003-01-16
CA2426158A1 (en) 2002-06-13
IL155400A0 (en) 2003-11-23
YU30203A (sh) 2006-08-17
SK5762003A3 (en) 2003-11-04
CN1620420A (zh) 2005-05-25
IS6789A (is) 2003-04-15
NO20031743D0 (no) 2003-04-15
MXPA03003459A (es) 2005-04-29
ES2206082T1 (es) 2004-05-16

Similar Documents

Publication Publication Date Title
HRP20030392A2 (en) Crystalline venlafaxine base and novel polymorphsof venlafaxine hydrochloride, processes for preparing thereof
US20080167498A1 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
WO2009070314A2 (en) Crystalline form of sitagliptin
KR102266680B1 (ko) 벨리노스테트의 다형태 및 이의 제조 방법
CA3126096A1 (en) Methods for producing viloxazine salts and novel polymorphs thereof
TW201736392A (zh) 一種奧貝膽酸的新結晶形式及其製備方法
US20180339964A1 (en) The process of preparing indoline compounds and a novel indolinesalt
SI21850A (sl) Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
MX2008011485A (es) Procedimiento para la preparacion de la forma polimorfa i de sulfato hidrogenado de (s)-{+)-metil-a-(2-clorofenil)-6,7-dihidro- tieno-[3,2-c]piridin-5{4h)-acetato.
KR20090073231A (ko) ３-(１ｈ-인돌-３-일)-４-[２-(４-메틸-피페라진-１-일)-퀴나졸린-４-일]-피롤-２,５-디온의 결정 변체
EP4063351A1 (en) Preparation method of quinoline derivative compounds
ZA200302768B (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
HRP20030631A2 (en) An improved process for preparing pure ondansetron hydrocloride dihydrate
WO2009027766A2 (en) New crystalline solid forms of o-desvenlafaxine base
EP4219443A1 (en) Method for preparing intermediate for synthesis of sphingosine-1-phosphate receptor agonist
US20050171145A1 (en) Process for the preparation of 2-(ethoxymethyl)-tropane derivatives
WO2009118758A2 (en) Novel crystalline forms of desvenlafaxine succinate

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20071010

Year of fee payment: 7

ODBI Application refused